Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Manzano RP, Peyman GA, Khan P, Kivilcim M . Testing intravitreal toxicity of bevacizumab (Avastin). Retina 2006; 26 (3): 257–261.
Amselem L, Cervera E, Díaz-Llopis M, Montero J, Garcia-Pous M, Udaondo P et al. Intravitreal bevacizumab (Avastin) for choroidal metastasis secondary to breast carcinoma: short-term follow-up. Eye 2007; 21 (4): 566–567.
Kuo IC, Haller JA, Maffrand R, Sambuelli RH, Reviglio VE . Regression of a subfoveal choroidal metastasis of colorectal carcinoma after intravitreous bevacizumab treatment. Arch Ophthalmol 2008; 126 (9): 1311–1313.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Lin, CJ., Li, KH., Hwang, JF. et al. The effect of intravitreal bevacizumab treatment on choroidal metastasis of colon adenocarcinoma—case report. Eye 24, 1102–1103 (2010). https://doi.org/10.1038/eye.2009.257
Published:
Issue date:
DOI: https://doi.org/10.1038/eye.2009.257
This article is cited by
-
Intravitreal bevacizumab for choroidal metastases: the key to efficacy is simultaneous administration of systemic therapy
Eye (2015)
-
Failure of intravitreal bevacizumab in the treatment of choroidal metastasis
Eye (2015)
-
Combination of intravitreal bevacizumab and systemic therapy for choroidal metastases from lung cancer: report of two cases and a systematic review of literature
Medical Oncology (2014)
-
Ocular metastases
Eye (2013)
